Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2 clinical trials
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2

enalapril in patients with heart failure (HF), reduced ejection fraction (EF), and increased brain natriuretic peptide (BNP) or N-terminal pro-BNP (NT-proBNP) in the PARADIGM-HF trial.1 The PIONEER-HF study

beta blockers
natriuretic peptide
ejection fraction
potassium
nesiritide
  • 2 views
  • 14 Jun, 2022
  • 1 location
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3

This is a double-blind, randomized, two x two crossover (aprepitant vs placebo) during both initiation of Entresto, LCZ696, (50 mg dose) and at steady-state of Entresto (200 mg bid dose or the highest tolerated dose).

vasodilator
angiotensin ii receptor antagonists
enalapril
beta blockers
natriuretic peptide
  • 0 views
  • 15 Jun, 2022
  • 1 location